ClinicalTrials.Veeva

Menu

Chongqing Diabetes Registry Study (CDR)

C

Chongqing Medical University

Status

Enrolling

Conditions

Diabetes Mellitus

Study type

Observational

Funder types

Other

Identifiers

NCT03692884
CDR2018

Details and patient eligibility

About

To investigate the risk factors and biomarkers of the microvascular disease,macrovascular disease and neuropathy in patients with diabetes.

Full description

This study is a prospective cohort study. About 5000 patients with diabetes from the Chongqing Diabetes Centre,Chongqing,China, will be enrolled for long-term follow-up.Information on socio-demographic parameters, medical history, current drug use,lifestyle factors, anthropometric measurements, metabolic control indicators and diabetes complications examination will be documented. Blood and urine samples will be collected. This study aimed to assess risk factors and biomarkers of occurrence and development of diabetic microvascular disease,macrovascular disease and neuropathy in patients with diabetes.

Enrollment

5,000 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Diagnosis of diabetes mellitus(based on the 1999 WHO diagnostic cretirial);
  2. Age younger than 75 years old, gender is not limited;
  3. Voluntary to sign on the informed consent.

Exclusion criteria

  1. pregnant or breast-feeding women;
  2. Patients with chronic disease requiring long-term glucocorticoid therapy;
  3. Patients with severe infection (except for diabetic foot) or immune dysfunction.

Trial contacts and locations

1

Loading...

Central trial contact

Qifu Li, phD; Zhihong Wang, phD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems